Omid Hamid, MD | Authors


Current and Emerging Immunotherapeutic Strategies in Melanoma

November 12, 2016

Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, discusses current and emerging immunotherapeutic strategies in the field of melanoma during an interview at the 34th Annual Chemotherapy Foundation SymposiumTM.

Treatment Decisions for Patients With Melanoma

October 22, 2013

Omid Hamid, MD, chief, translational research and immunotherapy, director, cutaneous oncology and melanoma, The Angeles Clinic and Research Institute, discusses treatment decisions for patients with melanoma.